SQM Porter's Five Forces Analysis

Extraction of lithium from brine and specialty chemical production demand proprietary evaporators, centrifuges and ion-exchange systems; SQM spent about $520m on plant capex and maintenance in 2024, reflecting reliance on specialized kit. SQM uses a global network of engineering firms for upgrades and uptime, often tied to multi-year service contracts covering 60–80% of critical equipment. These suppliers face high switching costs and limited substitutes, giving them moderate bargaining power over price and SLAs. In 2024, spare-part lead times averaged 14–22 weeks, raising supplier leverage.

State control of Salar de Atacama and a CORFO‑Codelco alliance through 2060 gives suppliers high leverage over SQM’s extraction rights and royalties, directly threatening EBITDA and capex plans.

Utilities, water rights, and specialized equipment/service vendors hold moderate–high power: desalination ~30% of water (2024), 500 MW renewables contracted (2025), spare‑part lead times 14–22 weeks, plant capex ~$520m (2024).

Union actions and scarce chemical inputs (sulfuric acid +18% in 2024) add disruption risk and input‑price pass‑through to margins.

In iodine, pharma and X-ray contrast makers demand >99.8% purity and continuity; global buyers like GE HealthCare and Bayer represent ~30% of industrial demand, so they're influential.

High re-qualification costs—often $1–5m and 6–18 months per supplier—give SQM pricing protection and lower churn.

If SQM slips on quality or supply, buyers can switch to rivals such as Israel Chemicals (ICL), which held ~22% market share in 2024, so the threat remains.

Customers hold high bargaining power: concentrated battery makers and distributors drove long-term offtakes (~60% of lithium sales) and ~45% revenue concentration among top 5 buyers in 2024, forcing 8–12% offtake discounts and spot-linked pricing (spot-linked sales +30% in 2024). High re-qualification costs ($1–5m, 6–18 months) limit churn in iodine, but buyers still push market-benchmark formulas.

In specialty plant nutrients, SQM competes with Yara International and ICL on product innovation and technical support, with 2024 R&D spending for the trio roughly $350–420m combined in specialty lines (SQM ~ $90m); potassium-based formulations are core. Brand reputation and local distribution drive sales—SQM held ~12% global specialty K market share in 2024, Yara ~18%, ICL ~10%. Rivalry is fiercest in high-value horticulture where trials show 5–12% yield lifts justify 15–30% price premiums.

SQM faces intense price and capacity rivalry in lithium—global refined capacity ~1.8M t LCE/yr by end-2025 (up ~22% since 2023) and lithium carbonate spot prices down ~35% vs 2023—pressuring EBITDA; SQM 2024 lithium COGS ~$1,400/t. In iodine SQM holds ~20% share (~8,000 t of 40,000 t global 2024 output) vs ICL. DLE funding ~$1.2bn (2024) and China ~60% refined processing (2025) raise strategic risks.

SQM’s specialty nutrients face substitution risk from cheaper standard fertilizers: if premiums exceed ~20–30% farmers often switch to potassium chloride or urea, cutting demand for potassium nitrate (SQM). In 2024 global fertilizer prices fell ~18% versus 2022 peaks, narrowing specialty margins and raising substitution. Precision ag and biologicals (market ~USD 2.5bn in 2024, CAGR ~10%) can lower chemical fertilizer volumes, further pressuring SQM’s specialty sales.

Substitutes (sodium‑ion, solid‑state, recycling, hydrogen, bio/precision ag) can trim SQM’s lithium and specialty margins; recycling supplied ~14 kt LCE (2024) ≈2–3% demand, solid‑state investment >$2B (2024), sodium‑ion pilots >100 MWh (2024). If recycling hits 20% of supply or lithium TAM falls 20–40% by 2030, SQM’s battery revenue (58% in 2024) and specialty premiums face material pressure.

SQM’s decades of proprietary brine chemistry and fractional crystallization know-how, honed since the 1960s at Salar de Atacama, is hard for new entrants to match; pilot projects typically show 20–40% lower lithium yields and 15–30% higher operating costs during scale-up. Managing Atacama’s ion balance to produce >99.5% lithium carbonate and commercially viable iodine yields requires process control and reagents that can take 5–7 years and >$200m in capex to optimize. These technical barriers create a durable moat, raising time-to-market and breakeven hurdles for rivals.

High capex ($500M–$2B), long lead times (8–15 years), tight Chilean permits (4–6+ years), water limits (−30% allocations 2024), ESG financing penalties (+150–300 bp), and SQM scale (~25% global share; >2.5 Mt LCE capacity 2024) keep threat of new entrants low; newcomers face 20–50% higher OPEX and 20–40% lower yields, raising breakeven and time-to-market barriers.